These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 29371016)
1. High glucose up-regulates microRNA-34a-5p to aggravate fibrosis by targeting SIRT1 in HK-2 cells. Xue M; Li Y; Hu F; Jia YJ; Zheng ZJ; Wang L; Xue YM Biochem Biophys Res Commun; 2018 Mar; 498(1):38-44. PubMed ID: 29371016 [TBL] [Abstract][Full Text] [Related]
2. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells. Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323 [TBL] [Abstract][Full Text] [Related]
3. Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease. Wang Y; Zheng ZJ; Jia YJ; Yang YL; Xue YM J Transl Med; 2018 May; 16(1):146. PubMed ID: 29848325 [TBL] [Abstract][Full Text] [Related]
4. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy. Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566 [TBL] [Abstract][Full Text] [Related]
5. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A. Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928 [TBL] [Abstract][Full Text] [Related]
6. LincRNA 1700020I14Rik alleviates cell proliferation and fibrosis in diabetic nephropathy via miR-34a-5p/Sirt1/HIF-1α signaling. Li A; Peng R; Sun Y; Liu H; Peng H; Zhang Z Cell Death Dis; 2018 May; 9(5):461. PubMed ID: 29700282 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy. Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287 [TBL] [Abstract][Full Text] [Related]
8. miR-192 prevents renal tubulointerstitial fibrosis in diabetic nephropathy by targeting Egr1. Liu F; Zhang ZP; Xin GD; Guo LH; Jiang Q; Wang ZX Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4252-4260. PubMed ID: 30024615 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MALAT1 interacts with transcription factor Foxo1 to regulate SIRT1 transcription in high glucose-induced HK-2 cells injury. Zhou L; Xu DY; Sha WG; Shen L; Lu GY Biochem Biophys Res Commun; 2018 Sep; 503(2):849-855. PubMed ID: 29928873 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy. Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899 [TBL] [Abstract][Full Text] [Related]
11. P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1. Li Q; Kim YR; Vikram A; Kumar S; Kassan M; Gabani M; Lee SK; Jacobs JS; Irani K Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2394-2403. PubMed ID: 27789474 [TBL] [Abstract][Full Text] [Related]
12. MiR-138-5p promotes TNF-α-induced apoptosis in human intervertebral disc degeneration by targeting SIRT1 through PTEN/PI3K/Akt signaling. Wang B; Wang D; Yan T; Yuan H Exp Cell Res; 2016 Jul; 345(2):199-205. PubMed ID: 27207584 [TBL] [Abstract][Full Text] [Related]
13. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517 [TBL] [Abstract][Full Text] [Related]
14. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells. Huang K; Chen C; Hao J; Huang J; Wang S; Liu P; Huang H Mol Cell Endocrinol; 2015 Jan; 399():178-89. PubMed ID: 25192797 [TBL] [Abstract][Full Text] [Related]
15. MiR-34a contributes to diabetes-related cochlear hair cell apoptosis via SIRT1/HIF-1α signaling. Lin Y; Shen J; Li D; Ming J; Liu X; Zhang N; Lai J; Shi M; Ji Q; Xing Y Gen Comp Endocrinol; 2017 May; 246():63-70. PubMed ID: 28263817 [TBL] [Abstract][Full Text] [Related]
16. Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT. Choi SE; Fu T; Seok S; Kim DH; Yu E; Lee KW; Kang Y; Li X; Kemper B; Kemper JK Aging Cell; 2013 Dec; 12(6):1062-72. PubMed ID: 23834033 [TBL] [Abstract][Full Text] [Related]
17. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1. Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells. Feili X; Wu S; Ye W; Tu J; Lou L Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876 [TBL] [Abstract][Full Text] [Related]
19. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy. Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438 [TBL] [Abstract][Full Text] [Related]
20. Circ_WBSCR17 aggravates inflammatory responses and fibrosis by targeting miR-185-5p/SOX6 regulatory axis in high glucose-induced human kidney tubular cells. Li G; Qin Y; Qin S; Zhou X; Zhao W; Zhang D Life Sci; 2020 Oct; 259():118269. PubMed ID: 32798559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]